{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T08:11:29Z","timestamp":1769501489226,"version":"3.49.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T00:00:00Z","timestamp":1559952000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T00:00:00Z","timestamp":1559952000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872052"],"award-info":[{"award-number":["81872052"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s11060-019-03198-9","type":"journal-article","created":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T18:10:37Z","timestamp":1560017437000},"page":"11-20","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Non-NF2 mutations have a key effect on inhibitory immune checkpoints and tumor pathogenesis in skull base meningiomas"],"prefix":"10.1007","volume":"144","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4224-9424","authenticated-orcid":false,"given":"Shuyu","family":"Hao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanyou","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,8]]},"reference":[{"issue":"3","key":"3198_CR1","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s00701-012-1611-y","volume":"155","author":"JF Cornelius","year":"2013","unstructured":"Cornelius JF, Slotty PJ, Steiger HJ, H\u00e4nggi D, Polivka M, George B (2013) Malignant potential of skull base versus non-skull base meningiomas: clinical series of 1663 cases. Acta Neurochir 155(3):407\u2013413","journal-title":"Acta Neurochir"},{"issue":"1","key":"3198_CR2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/00006123-199607000-00002","volume":"39","author":"T Mathiesen","year":"1996","unstructured":"Mathiesen T, Lindquist C, Kihlstrom L, Karlsson B (1996) Recurrence of cranial base meningiomas. Neurosurgery. 39(1):2\u20137 discussion 8-9","journal-title":"Neurosurgery."},{"issue":"1","key":"3198_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3171\/2014.7.JNS131644","volume":"122","author":"L Rogers","year":"2015","unstructured":"Rogers L, Barani I, Chamberlain M, Kaley TJ, McDermott M, Raizer J et al (2015) Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review. J Neurosurg. 122(1):4\u201323","journal-title":"J Neurosurg."},{"key":"3198_CR4","unstructured":"Network NCC. Central Nervous System Cancer (Version I, 2017) \n                              https:\/\/www.nccnorg\/professionals\/physician_gls\/pdf\/cnspdf\n                              \n                            Accessed 14 Jan 2018"},{"issue":"4","key":"3198_CR5","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1055\/s-2007-1016956","volume":"18","author":"A Nanda","year":"2008","unstructured":"Nanda A, Vannemreddy P (2008) Recurrence and outcome in skull base meningiomas: do they differ from other intracranial meningiomas? Skull Base 18(4):243\u2013252","journal-title":"Skull Base"},{"issue":"3\u20134","key":"3198_CR6","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.wneu.2011.11.018","volume":"78","author":"BK Misra","year":"2012","unstructured":"Misra BK (2012) The paradigm of skull base meningiomas: what is optimal? World Neurosurg 78(3\u20134):220\u2013221","journal-title":"World Neurosurg"},{"issue":"5","key":"3198_CR7","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.3171\/2010.2.JNS091118","volume":"113","author":"T Ichinose","year":"2010","unstructured":"Ichinose T, Goto T, Ishibashi K, Takami T, Ohata K (2010) The role of radical microsurgical resection in multimodal treatment for skull base meningioma. J Neurosurg 113(5):1072\u20131078","journal-title":"J Neurosurg"},{"issue":"12","key":"3198_CR8","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/S1474-4422(06)70625-1","volume":"5","author":"MJ Riemenschneider","year":"2006","unstructured":"Riemenschneider MJ, Perry A, Reifenberger G (2006) Histological classification and molecular genetics of meningiomas. Lancet Neurol 5(12):1045\u20131054","journal-title":"Lancet Neurol"},{"issue":"6123","key":"3198_CR9","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1126\/science.1233009","volume":"339","author":"VE Clark","year":"2013","unstructured":"Clark VE, Erson-Omay EZ, Serin A, Yin J, Cotney J, Ozduman K et al (2013) Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO. Science 339(6123):1077\u20131080","journal-title":"Science"},{"issue":"3","key":"3198_CR10","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/ng.2526","volume":"45","author":"PK Brastianos","year":"2013","unstructured":"Brastianos PK, Horowitz PM, Santagata S, Jones RT, McKenna A, Getz G et al (2013) Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations. Nat Genet 45(3):285\u2013289","journal-title":"Nat Genet"},{"issue":"2","key":"3198_CR11","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3171\/2016.8.JNS161076","volume":"127","author":"MR Strickland","year":"2017","unstructured":"Strickland MR, Gill CM, Nayyar N, D\u2019Andrea MR, Thiede C, Juratli TA et al (2017) Targeted sequencing of SMO and AKT1 in anterior skull base meningiomas. J Neurosurg 127(2):438\u2013444","journal-title":"J Neurosurg"},{"issue":"1","key":"3198_CR12","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s10555-016-9652-y","volume":"36","author":"Y Khagi","year":"2017","unstructured":"Khagi Y, Kurzrock R, Patel SP (2017) Next generation predictive biomarkers for immune checkpoint inhibition. Cancer Metastasis Rev 36(1):179\u2013190","journal-title":"Cancer Metastasis Rev"},{"issue":"1","key":"3198_CR13","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1530\/ERC-12-0313","volume":"20","author":"LL Cunha","year":"2013","unstructured":"Cunha LL, Marcello MA, Morari EC, Nonogaki S, Conte FF, Gerhard R et al (2013) Differentiated thyroid carcinomas may elude the immune system by B7H1 upregulation. Endocr Relat Cancer 20(1):103\u2013110","journal-title":"Endocr Relat Cancer"},{"issue":"7","key":"3198_CR14","doi-asserted-by":"publisher","first-page":"4704","DOI":"10.18632\/oncotarget.3082","volume":"6","author":"Z Du","year":"2015","unstructured":"Du Z, Abedalthagafi M, Aizer AA, Mchenry AR, Sun HH, Bray MA et al (2015) Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningioma. Oncotarget 6(7):4704\u20134716","journal-title":"Oncotarget"},{"issue":"3","key":"3198_CR15","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s11060-016-2256-0","volume":"130","author":"SJ Han","year":"2016","unstructured":"Han SJ, Reis G, Kohanbash G, Shrivastav S, Magill ST, Molinaro AM et al (2016) Expression and prognostic impact of immune modulatory molecule PD-L1 in meningioma. J Neurooncol 130(3):543\u2013552","journal-title":"J Neurooncol"},{"issue":"1","key":"3198_CR16","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13045-018-0644-y","volume":"11","author":"M Liu","year":"2018","unstructured":"Liu M, Wang X, Wang L, Ma X, Gong Z, Zhang S et al (2018) Targeting the IDO1 pathway in cancer: from bench to bedside. J Hematol Oncol. 11(1):100","journal-title":"J Hematol Oncol."},{"key":"3198_CR17","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ejca.2017.01.011","volume":"76","author":"L Brochez","year":"2017","unstructured":"Brochez L, Chevolet I, Kruse V (2017) The rationale of indoleamine 2,3-dioxygenase inhibition for cancer therapy. Eur J Cancer 76:167\u2013182","journal-title":"Eur J Cancer"},{"issue":"4","key":"3198_CR18","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s11011-016-9824-z","volume":"31","author":"CP Yu","year":"2016","unstructured":"Yu CP, Pan ZZ, Luo DY (2016) TDO as a therapeutic target in brain diseases. Metab Brain Dis 31(4):737\u2013747","journal-title":"Metab Brain Dis"},{"issue":"7368","key":"3198_CR19","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nature10491","volume":"478","author":"CA Opitz","year":"2011","unstructured":"Opitz CA, Litzenburger UM, Sahm F, Ott M, Tritschler I, Trump S et al (2011) An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature 478(7368):197\u2013203","journal-title":"Nature"},{"issue":"7","key":"3198_CR20","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1073\/pnas.1113873109","volume":"109","author":"L Pilotte","year":"2012","unstructured":"Pilotte L, Larrieu P, Stroobant V, Colau D, Dolusic E, Frederick R et al (2012) Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase. Proc Natl Acad Sci USA 109(7):2497\u20132502","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"3198_CR21","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s12032-017-0933-2","volume":"34","author":"CP Yu","year":"2017","unstructured":"Yu CP, Song YL, Zhu ZM, Huang B, Xiao YQ, Luo DY (2017) Targeting TDO in cancer immunotherapy. Med Oncol 34(5):73","journal-title":"Med Oncol"},{"issue":"11","key":"3198_CR22","doi-asserted-by":"publisher","first-page":"e112945","DOI":"10.1371\/journal.pone.0112945","volume":"9","author":"S Adams","year":"2014","unstructured":"Adams S, Teo C, McDonald KL, Zinger A, Bustamante S, Lim CK et al (2014) Involvement of the kynurenine pathway in human glioma pathophysiology. PLoS ONE 9(11):e112945","journal-title":"PLoS ONE"},{"issue":"1","key":"3198_CR23","doi-asserted-by":"publisher","first-page":"e1512943","DOI":"10.1080\/2162402X.2018.1512943","volume":"8","author":"DT Proctor","year":"2018","unstructured":"Proctor DT, Patel Z, Lama S, Resch L, van Marle G, Sutherland GR (2018) Identification of PD-L2, B7-H3 and CTLA-4 immune checkpoint proteins in genetic subtypes of meningioma. Oncoimmunology 8(1):e1512943","journal-title":"Oncoimmunology"},{"issue":"6","key":"3198_CR24","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK et al (2016) The 2016 World Health Organization Classification of tumors of the central nervous system: a summary. Acta Neuropathol 131(6):803\u2013820","journal-title":"Acta Neuropathol"},{"issue":"8","key":"3198_CR25","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1093\/neuonc\/nox018","volume":"19","author":"\u00dc Yesil\u00f6z","year":"2017","unstructured":"Yesil\u00f6z \u00dc, Kirches E, Hartmann C, Scholz J, Kropf S, Sahm F et al (2017) Frequent AKT1E17K mutations in skull base meningiomas are associated with mTOR and ERK1\/2 activation and reduced time to tumor recurrence. Neuro-Oncology 19(8):1088\u20131096","journal-title":"Neuro-Oncology"},{"issue":"3","key":"3198_CR26","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00401-013-1093-x","volume":"125","author":"DE Reuss","year":"2013","unstructured":"Reuss DE, Piro RM, Jones DT, Simon M, Ketter R, Kool M et al (2013) Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations. Acta Neuropathol 125(3):351\u2013358","journal-title":"Acta Neuropathol"},{"issue":"1","key":"3198_CR27","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1021\/pr900834h","volume":"9","author":"O Saydam","year":"2010","unstructured":"Saydam O, Senol O, Schaaijvisser TB, Pham TV, Piersma SR, Stemmerrachamimov AO et al (2010) Comparative protein profiling reveals minichromosome maintenance (MCM) proteins as novel potential tumor markers for meningiomas. J Proteome Res 9(1):485\u2013494","journal-title":"J Proteome Res"},{"issue":"2","key":"3198_CR28","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00251-017-1015-5","volume":"70","author":"A Salmaninejad","year":"2017","unstructured":"Salmaninejad A, Khoramshahi V, Azani A, Soltaninejad E, Aslani S, Zamani MR et al (2017) PD-1 and cancer: molecular mechanisms and polymorphisms. Immunogenetics 70(2):73\u201386","journal-title":"Immunogenetics"},{"issue":"1","key":"3198_CR29","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.molmed.2014.10.009","volume":"21","author":"KC Ohaegbulam","year":"2015","unstructured":"Ohaegbulam KC, Assal A, Lazar-Molnar E, Yao Y, Zang X (2015) Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway. Trends Mol Med 21(1):24\u201333","journal-title":"Trends Mol Med"},{"issue":"2","key":"3198_CR30","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1093\/neuonc\/nov172","volume":"18","author":"EK Nduom","year":"2016","unstructured":"Nduom EK, Wei J, Yaghi NK, Huang N, Kong LY, Gabrusiewicz K et al (2016) PD-L1 expression and prognostic impact in glioblastoma. Neuro Oncol 18(2):195\u2013205","journal-title":"Neuro Oncol"},{"issue":"13","key":"3198_CR31","doi-asserted-by":"publisher","first-page":"11139","DOI":"10.18632\/oncotarget.3576","volume":"6","author":"Y Feng","year":"2015","unstructured":"Feng Y, Shen J, Gao Y, Liao Y, Cote G, Choy E et al (2015) Expression of programmed cell death ligand 1 (PD-L1) and prevalence of tumor-infiltrating lymphocytes (TILs) in chordoma. Oncotarget 6(13):11139\u201311149","journal-title":"Oncotarget"},{"issue":"1","key":"3198_CR32","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s40880-017-0262-z","volume":"36","author":"LY Hu","year":"2017","unstructured":"Hu LY, Xu XL, Rao HL, Chen J, Lai RC, Huang HQ et al (2017) Expression and clinical value of programmed cell death-ligand 1 (PD-L1) in diffuse large B cell lymphoma: a retrospective study. Chin J Cancer 36(1):94","journal-title":"Chin J Cancer"},{"key":"3198_CR33","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jocn.2018.08.023","volume":"57","author":"MD Johnson","year":"2018","unstructured":"Johnson MD (2018) PD-L1 expression in meningiomas. J Clin Neurosci 57:149\u2013151","journal-title":"J Clin Neurosci"},{"issue":"22","key":"3198_CR34","doi-asserted-by":"publisher","first-page":"6985","DOI":"10.1158\/1078-0432.CCR-11-1331","volume":"17","author":"J Godin-Ethier","year":"2011","unstructured":"Godin-Ethier J, Hanafi LA, Piccirillo CA, Lapointe R (2011) Indoleamine 2,3-dioxygenase expression in human cancers: clinical and immunologic perspectives. Clin Cancer Res 17(22):6985\u20136991","journal-title":"Clin Cancer Res"},{"issue":"22","key":"3198_CR35","doi-asserted-by":"publisher","first-page":"6110","DOI":"10.1158\/1078-0432.CCR-12-2130","volume":"18","author":"DA Wainwright","year":"2012","unstructured":"Wainwright DA, Balyasnikova IV, Chang AL, Ahmed AU, Moon KS, Auffinger B et al (2012) IDO expression in brain tumors increases the recruitment of regulatory T cells and negatively impacts survival. Clin Cancer Res 18(22):6110\u20136121","journal-title":"Clin Cancer Res"},{"issue":"1","key":"3198_CR36","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11060-016-2225-7","volume":"130","author":"NK Talari","year":"2016","unstructured":"Talari NK, Panigrahi M, Madigubba S, Challa S, Phanithi PB (2016) Altered tryptophan metabolism in human meningioma. J Neurooncol 130(1):69\u201377","journal-title":"J Neurooncol"},{"issue":"4","key":"3198_CR37","doi-asserted-by":"publisher","first-page":"333","DOI":"10.4161\/cbt.23624","volume":"14","author":"IM Zitron","year":"2013","unstructured":"Zitron IM, Kamson DO, Kiousis S, Juh\u00e1sz C, Mittal S (2013) In vivo metabolism of tryptophan in meningiomas is mediated by indoleamine 2,3-dioxygenase 1. Cancer Biol Ther 14(4):333\u2013339","journal-title":"Cancer Biol Ther"},{"issue":"9","key":"3198_CR38","first-page":"1284","volume":"17","author":"E Bosnyak","year":"2015","unstructured":"Bosnyak E, Kamson DO, Guastella AR, Varadarajan K, Robinette NL, Kupsky WJ et al (2015) Molecular imaging correlates of tryptophan metabolism via the kynurenine pathway in human meningiomas. Neuro Oncol 17(9):1284\u20131292","journal-title":"Neuro Oncol"},{"issue":"2","key":"3198_CR39","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s11060-018-2869-6","volume":"139","author":"AR Guastella","year":"2018","unstructured":"Guastella AR, Michelhaugh SK, Klinger NV, Fadel HA, Kiousis S, Ali-Fehmi R et al (2018) Investigation of the aryl hydrocarbon receptor and the intrinsic tumoral component of the kynurenine pathway of tryptophan metabolism in primary brain tumors. J Neurooncol 139(2):239\u2013249","journal-title":"J Neurooncol"},{"issue":"2","key":"3198_CR40","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/ncb1086","volume":"6","author":"T Bouwmeester","year":"2004","unstructured":"Bouwmeester T, Bauch A, Ruffner H, Angrand PO, Bergamini G, Croughton K et al (2004) A physical and functional map of the human TNF-alpha\/NF-kappa B signal transduction pathway. Nat Cell Biol 6(2):97\u2013105","journal-title":"Nat Cell Biol"},{"issue":"6","key":"3198_CR41","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1002\/jcp.25676","volume":"232","author":"T Zotti","year":"2017","unstructured":"Zotti T, Scudiero I, Vito P, Stilo R (2017) The emerging role of TRAF7 in tumor development. J Cell Physiol 232(6):1233\u20131238","journal-title":"J Cell Physiol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-019-03198-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-019-03198-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-019-03198-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,6]],"date-time":"2020-06-06T23:13:22Z","timestamp":1591485202000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-019-03198-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,8]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["3198"],"URL":"https:\/\/doi.org\/10.1007\/s11060-019-03198-9","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,8]]},"assertion":[{"value":"8 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All the authors declare there are no conflicts of interest regarding the publication of the paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}